Healthcare ❯ Pharmaceuticals

Drug Development

Clinical Trials Weight Loss Drugs Oncology Clinical Research GLP-1 Drugs Market Trends Regulatory Approval Obesity Treatment Regulatory Affairs Market Competition

IYH vs PJP: Diversified, Lower‑Cost Healthcare Fund Faces Concentrated Pharma Challenger

Investors must choose steadier, cheaper broad healthcare exposure or a smaller fund whose pharma focus has driven recent gains.

Kalshi Opens Betting Markets for Phase 3 Drug Trials and FDA Decisions

Sinopia’s SB-0110 Boosts Levodopa Benefit and Cuts Dyskinesia in Animal Models

Johnson & Johnson Beats Q2 Estimates and Lifts Full‑Year Outlook

Wegovy Pill Arrives in UK Private Market as Clinicians Flag Dosing and Safety Risks

HSE Refers Skyclarys Reimbursement to Rare Diseases Review Committee

Late‑Stage Trial of Wainua Misses Primary Goal in ATTR‑CM Study

Vertex to Acquire Crinetics for About $10 Billion

Healthcare ETFs Force a Choice Between Low Cost and Higher Growth

AbbVie Agrees to Buy Apogee Therapeutics for $10.9 Billion

Oral GLP‑1s Reshape Obesity Market as Approvals, Policy Talks and M&A Accelerate Growth

Eli Lilly's GLP‑1 Surge Leaves Pfizer as the High‑Yield Option

Eli Lilly Spends $3.8 Billion to Build Vaccine Business

Researchers Find 14‑Protein Blood Signature That Predicts Lung Cancer Years Ahead

Supreme Court Clears Path for Generic 'Skinny Labels' in Unanimous Hikma Ruling

Flu Drug Class Prevents Glycan Loss Linked to Cognitive Decline in People With HIV

Fulcrum Halts Pociredir Development After FDA Flags PRC2 Cancer Risk

Eli Lilly Rides Breakthrough Retatrutide Data and $4 Billion Vaccine Push to Record Highs

New Hepatitis B Drug Produces Functional Cure in About One in Five Patients

Bepirovirsen Achieves Functional Cure in About One in Five People With Chronic Hepatitis B